VS News and Press, Versus Systems Inc. From 01/03/24

LOS ANGELES, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Versus Systems Inc. (“Versus” or the “Company”) (Nasdaq: VS) is pleased to announce that the shareholders of the Company approved all matters at its Annual General Meeting held on December 29, 2023, as follows: the...

2023-12-29 08:02:08 ET Versus Systems Inc (VS) announced stock split at a ratio of 1-for-16 on 2023-12-29 ... Full story available on KlickAnalytics.com

2023-11-24 12:32:41 ET More on Technology Select Sector Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble XLK: Big Tech Emerging As Beacon Of Value XLK: Themes To Watch In Tech Stocks Ahead Of Q3 Earnings Bespo...

2023-11-24 11:20:37 ET More on Mid-day movers stock. Breaking: Bitcoin ETFs On The Verge Of Approval; Position For The Crypto Moon With Bakkt Bakkt Holdings, Inc. 2023 Q3 - Results - Earnings Call Presentation Bakkt Holdings, Inc. (BKKT) Q3 2023 Earnings Call Transcr...

LOS ANGELES, Nov. 24, 2023 (GLOBE NEWSWIRE) -- Versus Systems Inc. (“Versus” or the “Company”) (Nasdaq: VS) announced today that the Company recently secured a strategic investment (the “Investment”) from Cronus Equity Capital Group, LLC (“CECG...

INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...

Versus Systems Inc. (VS) is expected to report $-0.18 for Q3 2023

2023-10-31 10:04:17 ET DENVER, Colo., Oct. 31, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Cardio Diagnostics Holdings Inc (NASDAQ: CDIO), X4 Pharmaceuticals Inc (NASDAQ: XFOR), SciSparc Ltd (NASDAQ: ...

LOS ANGELES, Oct. 13, 2023 (GLOBE NEWSWIRE) -- Versus Systems Inc. (“Versus” or the “Company”) (NASDAQ: VS), today announced the pricing of its reasonable best efforts public offering of 13,043,490 of its common shares (or common share equivalents in lieu thereof) and ...

2023-10-12 13:26:41 ET More on Femasys, Jaguar Health, etc. Jaguar Health, Inc. (JAGX) Q2 2023 Earnings Call Transcript LogicMark, Inc. (LGMK) Q2 2023 Earnings Call Transcript Femasys regains Nasdaq compliance Jaguar Health's Napo Pharma gets patent in Japan ...